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Abstract: In invasive radiology, X-ray imaging is used in both tracking the delivery system 
and assisting in correct positioning of stents. Until now there has been no objective and 
quantitative scale of X-ray visibility which is also known as radiopacity. There is a clear 
need from the part of interventional cardiologists for a quantitative in vitro evaluation 
method with which X-ray visibility can be graded repeatably, objectively, in a validated 
form across a wide range of fields. Therefore the development of the presented quantitative 
evaluation approach was decided in order to unambiguously classify the radiopacity of 
given cardiovascular implants under given in vitro imaging conditions. In this work the 
relative X-ray visibility index (XVR), which expresses the visibility of the stent compared to 
the background and the method for determining the value of this index, is introduced. The 
XVR index is related to a simple quantification method based on image analysis of X-ray 
images of stents. Nevertheless, this stent radiopacity quantification method can also be 
used in a wide range of clinical contexts. 
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1 Introduction 
Invasive coronary angiography and percutaneous coronary angioplasty are the 
most important clinical processes for the assessment and therapy of coronary ar-
tery stenoses. In the revascularization process a high-resolution X-ray fluoroscope 
helps the interventional cardiologists to control the position of the stent. As bio-
medical product, stents have many important and strictly evaluated technical char-
acteristics which form the basis of their comparison when choosing in the market. 
For these reasons the X-ray visibility is one of the most important functional prop-
erties of the stents [1, 2, 3]. 
Satisfactory X-ray visibility – which property is often called as “radiopacity” and 
sometimes as “radiovisibility” [4] or “radiodensity” – relies on a certain level of 
X-ray attenuation caused by the material of the stent. As a simple definition, radi-
opacity of a medical device or implant is the ability to absorb X-rays or reduce 
their permeation [5]. The attribute “radiopaque” is used to describe the ability of a 
substance to absorb X-rays and appear opaque (white) on radiographs [6]. Without 
a satisfactory visibility, the interventional cardiologists cannot oversee the location 
of the stent and its positioning into the stenosed artery precisely on the display of 
X-ray fluoroscope. 
Whereas a standard exists [7] proposing a method for determination of the visibil-
ity of catheters, the ISO 25539-2:2008 standard [8] for vascular stents does not 
specify the precise test protocol. Because of this, assessment tests for classifying 
the visibility are carried out in numerous ways, but both stent producers and end-
users use nowadays generally a subjective classification such as “good”, “very 
good”, “excellent”, “average”, “poor”, “low”, “high”, etc. [9, 10]. An often used 
method is to characterize X-ray images by their average greyscale level on a 256 
level scale. A stent or stent system is evaluated by the difference between the 
greyscale value of the stent and that of the surrounding area in the picture. [11, 
12]. Another evaluation of stents or stent markers is possible by using a “graphic 
depiction” of marking on the radiograph [13] even more automatically in the 
fluoroscopy images [14, 15]. 
Elements that have high density and high atomic number, such as Pt, Ir, Ta, Nb, 
Pd, W, Mo strongly enhance the radiopacity compared to Fe, Cr, Ni, Co. This ef-
fect is used for example in case of Taxus Element Stent (37Fe-33Pt-18Cr-9Ni-
2,6Mo), whiches thinner struts do not cause a reduction in stent visibility. Similar-
ly, an excellent radiographic visibility characterizes the Wallstent; it consists of 
round wire struts of Co-Cr alloy but the composite wire has an inner core of Pt 
[16]. 
Comparing titanium, Ti–50Ta, Ti–45Ta–5Ir [17] and Nb-based alloys [18, 19] 
were found much more radiopaque. The producer of the ZoMaxx Stent developed 
a layered composite, in which the inner tantalum layer significantly improves ra-
diopacity of the thin stent struts [20]. In order to improve the radiopacity the ends 
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of some stents are coated with gold markers [21] and dysprosium markers for vis-
ualizing the catheters [22]. 
There are many other works in which the authors evaluate the visibility of stents 
produced of Nitinol [23, 24, 25, 26], Co-Cr, Co-Pt, 316L [27, 28] and magnesium 
[29] but not having a clear quantitative method, the results remain inaccurate. 
Some research is based on multi-slice computer tomography [30, 31]. The aim of 
these studies in the beginning was to investigate the stent expansion process, [32] 
afterwards to define the “stent lumen visibility” at in vitro conditions [33] or after 
the insertion of the stent [34, 35, 36, 37, 38]. CT scans were valued on a four or 
five-degree scale from “excellent” to “not gradable”, etc. [39]. The drawback of 
this type of classification is that removal of subjective elements from the evalua-
tion is not possible. 
More different interpretations of term visibility have appeared applied in connec-
tion with invasive radiology: “stent visibility rate” was defined as the proportion 
of visible and the total length of the stent at the CT imaging [40], and “visibility-
index” was generated from geometric data coming from quantitative coronary 
analysis (QCA) and IVUS-data [41]. A formula was described to provide a quanti-
tative measure of the contrast between an object and the surrounding background. 
Different aspects of the imaging of a coronary stent were analyzed and it was stat-
ed that the general condition for X-ray visibility an object must fulfill, is to pro-
vide a level of contrast within the area where it is projected which is sufficient to 
be detected above the noise level of the image [42]. All these above summarized 
research could not result in such method, neither for the producers and nor for the 
end-users, which makes quantitative determination of stent visibility possible sim-
ilarly to other functional parameters of stents (i.e. recoil, radial strength, metallic 
surface area, etc.). 
There is a clear need for a quantitative evaluation method to grade X-ray visibility 
of stents, and to compare the different types quantitatively. It should be easily rep-
licable, defined on an objective numerical scale, usable in a wide range of fields, 
and standardized to the point where it can be routinely applied in measuring X-ray 
visibility. The objective of this work was the elaboration of an in vitro method 
which meets each of the following conditions among the needs: objectively char-
acterizes X-ray visibility, gives a quantitative result and permits comparing differ-
ent sizes, materials and types of stents. 
2 Method for Imaging the Stent 
The new in vitro method for quantification of the visibility will be presented in the 
followings through the example of two coronary stents. One of them is a CoStar 
(2.5×18 mm) stent, the other one is a PRO-Kinetic (3.0×15 mm) stent; both are 
made of ASTM F 90 standard specified L-605 type Co-Cr alloy. 
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The first step of the in vitro quantification method is to obtain an X-ray microsco-
py (XRM) image of the stent preferably with the same voltage and cathode heat-
ing parameters as in clinical practice. For this a Dage XiDAT XD6600 type X-ray 
microscope was used. The three test values of cathode heating were 800, 1000 and 
1200 mW, but the accelerating voltage was fixed at 90 kV in each case. 
Using these X-ray imaging parameters, images were obtained in which the con-
trast and middle-tone values differ; two XRM images are shown in Fig. 1 taken 
after balloon expansion of stents. It is also noticeable that in XRM images there 
are perceptibly different tones at image points in the background. 
The X-ray detector renders the cylindrical, lattice-like structure of the implant as a 
flat projection. The XRM images obtained in this way vary apparently along dif-
ferent imaging parameters applied, or locate the metallic strut of the stent in a ran-
dom position as Fig. 2 shows. In the nine XRM images the same section of one 
stent is visible rotated into three distinct random orientations around its axis. 
These effects will be discussed in a further paper based on the work of a corre-
sponding PhD thesis [43], because it is obvious that all different positions and dif-
ferent cathode-heating levels can strongly increase the error of subjective evalua-
tion. Therefore it is needed for a long time to find a solution for the quantitative 
determination of visibility without errors caused by subjective evaluation. 
Apart from the XRM images of the stent, it is necessary for further analysis to 
have an XRM image of the empty background which image is obtained with abso-
lutely identical parameters. 
 
Figure 1 
X-ray microscopic image of the examined CoStar stent (a) and PRO-Kinetic stent (b); 
(as an example; the imaging parameters are intentionally different) 
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Figure 2 
Visibility window on the stent XRM image is defined as the rectangle, which has one side the length of 
the stent and the other side twice the width (diameter) of the stent; the centred stent is enclosed by the 
dotted rectangle; these image were taken at 90 kV tube voltage and 1200 mW cathode heating 
3 Method for Evaluating the XRM Images 
In order to overlay the two XRM images – the one with the stent and the other im-
age of only the background – an equally dimensioned and identically positioned 
so-called visibility window must be defined to line up and match the two images 
precisely. The image elements in terms of visibility will be interpreted in this win-
dow. When setting the dimensions of the visibility window medical experience 
and to the fact that visibility in every case strongly depends on the surrounding 
area and background must be taken into consideration. Fig. 3 helps to survey the 
definition and construction of visibility window for the CoStar stent. 
The visibility window is defined by sides a  and b  hence for the area abA  equa-
tions (1), (2), and (3) have the following values: 
La   (1) 
2
2
D
Db 
 (2) 
abS AA 2  (3) 
where L  is the length and D  is the diameter of the stent in its expanded state, SA  
is the surrounded area of the projection of the stent, and abA  is the area of the vis-
ibility window. In the next step the visibility windows must be analyzed as an 8-
bit, grayscale image since this is the picture format the interventional cardiologists 
see in practice. 
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Figure 3 
XRM images of two rings of a complete CoStar stent in three random rotated orientations,  
and three levels of cathode heating (at 90 kV tube voltages) 
4 Results: Properties of the Visibility Windows 
In the interests of defining a quantitative visibility parameter the distribution of 
number of pixels (N) of the visibility window must be analyzed according to the 
grayscale level (G). The values G = 0 and G = 255 correspond to the black and 
white color respectively. Fig. 4 and Fig. 5 show the grayscale histograms of visi-
bility windows; that for the data points when the image contains the stent,  GNS , 
and that for the data points when the image does not contain it,  GNB . 
The grayscale histogram of the stent-containing visibility window always shows a 
large interval in the dark pixels’ region; the dark pixels’ interval 
MINB
GG   is 
started at the darkest point of the background’s grayscale histogram (
MINB
G  = 
168 in Fig. 4 and Fig. 5). The area under the curve is proportional to the X-ray ab-
sorption of the stent, thus to the visibility, so it would be practical to define a visi-
bility parameter which clearly reflects this simple regularity. Moreover, similar 
grey-scale image based segmentation method was elaborated for analysis of the 
captured images of printed, folded-gathered substrates or spectrograms [44, 45]. 
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Figure 4 
Grayscale histograms (distribution of the pixels) of XRM images of the visibility windows  
for CoStar stent 
 
Figure 5 
X-ray microscopic image of the examined CoStar stent (a) and PRO-Kinetic stent (b) 
Let  GUS  and  GUB  be the visibility functions obtained by integration of the 
histogram of the stent containing and the empty visibility window,  GNS  
and  GNB . The integrals of the grayscale histograms match the shaded areas un-
der the two respective curves. The two integrals are given in equations (4) and (5), 
and the integral functions for the two examined stents are shown in Fig. 6 and 
Fig. 7. 
   
HG
LG
GGΝGU dSS  (4) 
   
HG
LG
GGΝGU dBB  (5) 
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Where  GNS  is the grayscale histogram function of the visibility window con-
taining the stent,  GNB  is the same of the background.  GUS  and  GUB  re-
spectively are the two integrals, so-called visibility functions. The limits 0LG  
and 255HG  are the respective boundary conditions, according to the extreme 
values of grayscale level. 
In the first developing phase of this visibility quantification method, the grayscale 
histograms were produced by using the image analyzer software, Image-Pro Plus, 
and the numerical integrations were carried out by using the software Microcal 
Origin. Parallel to the validation, improvement and large-scale application of this 
method, customized software was also developed which ensures to evaluate even 
a huge number of XRM images easily and quickly. 
 
Figure 6 
Visibility functions and areas under the curve of the stent-containing and the wide visibility window 
for CoStar stent 
 
Figure 7 
Visibility functions and areas under the curve of the stent-containing and the wide visibility window 
for PRO-Kinetic stent 
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5 Discussion: Computing the X-Ray Visibility 
Figure 6 shows the two visibility functions: one for data from the visibility win-
dow containing only the background (empty), the other for data from the visibility 
window containing the background and the stent. The two visibility windows con-
tain some image points with identical numerical values, and in fact the maximums 
of the two visibility functions are necessarily identical. 
As a dimensionless index, let us introduce, the relative X-ray visibility index, 
RXV , which expresses the visibility of the stent in comparison to the background 
within the visibility window. This is a proportional measure expressing the visibil-
ity of the stent as a percentage of the visibility of the background. From the ratio 
between the areas under the curve of the two visibility functions, the relative visi-
bility index, RXV , is defined by the following equation (6): 
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where S  and B  express the visibility number, respectively for the stent con-
taining and for the empty visibility window, on the basis of the 8-bit, grayscale 
XRM image. Equation (6) above derives these two terms from an expression for 
the double integral of the grayscale histogram of the XRM image. 
The RXV  index defined this way characterizes the X-ray visibility of the stent it-
self under given X-ray microscopy imaging conditions. This parameter is suitable 
for quantitative evaluation and comparison of the visibility of different stents – 
which differ in type, material, diameter or length – in which identical scanning 
conditions must be ensured. For the two stents which were shown as examples, the 
following XVR values were determined: 29.52% for the CoStar stent, and 20.15% 
for the PRO-Kinetic stent. 
Between identical scanning conditions the relative visibility index excellently de-
scribes even quite small differences in visibility. In place of subjective evaluations 
or scales used earlier, a quantitative method and parameter which accurately ranks 
subtle deviations was developed based on objective measurements. 
Conclusions 
In the course of this study, a new in vitro method of measurement for the charac-
terization of visibility (radiopacity) of stents was elaborated which objectively de-
scribes X-ray visibility providing quantitative results suitable for comparison of 
stents or catheters, guide-wires, markers and other cardiovascular devices. This 
objective, numerical index is suitable for routine use in evaluating radiopacity, as 
an in vitro method. 
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In clinical practice the elaborated method is suitable for assessing visibility pa-
rameters using 8-bit, grayscale X-ray microscopy (XRM) images. 
The relative X-ray visibility index, RXV , which characterizes the stent radiopacity 
under given X-ray microscopy conditions was introduced . This index is very ef-
fective for quantitative evaluation of the visibility of different stents – which differ 
in type, material, diameter or length – when identical scanning conditions are en-
sured. 
Moreover, the principle and the calculation method of the relative X-ray visibility 
index are easily adaptable for the quantitative evaluation of X-ray angiograms and 
their improving algorithms. 
Instead of the previously mentioned subjective evaluations or scales, the elaborat-
ed method has defined a quantitative feature which is based on objective data; 
consequently it permits precise ranking of subtle deviations. 
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